openPR Logo
Press release

US Generic Drug Market Size, Share, Key Players, Regional Analysis and Forecast 2023-2028

01-23-2023 08:23 AM CET | Health & Medicine

Press release from: IMARC Group

US Generic Drug Market Size, Share, Key Players, Regional

According to IMARC Group's latest report, titled "๐—จ๐—ฆ ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ถ๐—ฐ ๐——๐—ฟ๐˜‚๐—ด ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜: ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐˜€, ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—ฒ, ๐—ฆ๐—ถ๐˜‡๐—ฒ, ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต, ๐—ข๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜‚๐—ป๐—ถ๐˜๐˜† ๐—ฎ๐—ป๐—ฑ ๐—™๐—ผ๐—ฟ๐—ฒ๐—ฐ๐—ฎ๐˜€๐˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ-๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿด", The US generic drug market size reached US$ 86.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 110.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.

๐—ฌ๐—ฒ๐—ฎ๐—ฟ ๐—–๐—ผ๐—ป๐˜€๐—ถ๐—ฑ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐˜๐—ผ ๐—˜๐˜€๐˜๐—ถ๐—บ๐—ฎ๐˜๐—ฒ ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ถ๐˜‡๐—ฒ:

Base Year of the Analysis: 2022
Historical Period: 2017-2022
Forecast Period: 2023-2028

๐—จ๐—ฆ ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ถ๐—ฐ ๐——๐—ฟ๐˜‚๐—ด ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ข๐˜ƒ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฒ๐˜„:

A generic drug refers to an off-patent medication that is similar to the original drug in terms of strength, dosage, form, quality, efficacy, side effects, route of administration, and intended use. Such similarities allow for demonstrating bioequivalence, which means that a generic medicine works in the same way and delivers the same clinical help as the original medicine.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐—ฃ๐——๐—™ ๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ถ๐˜€ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜: https://www.imarcgroup.com/us-generics-market/requestsample

๐—จ๐—ฆ ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ถ๐—ฐ ๐——๐—ฟ๐˜‚๐—ด ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐˜€:

The rapid rise in the production of generic drugs across the United States is driving the market growth. In line with this, these drugs are cheaper as compared to their original counterparts as they do not need extensive testing and research. Apart from this, the increase in the introduction of generic drugs has enhanced the access of patients to healthcare. This is further leading to growing competition among the market players, which is supporting the market growth. Moreover, initiatives for generic drug approvals by the United States Government with the implementation of the FDA's Drug Competition Action Plan are bolstering the market growth in the country. In addition, the increasing awareness about generic drugs is further expected to fuel the market growth. Furthermore, the rising prevalence of numerous life-threatening diseases is projected to influence the market growth during the forecast period.

๐—–๐—ต๐—ฒ๐—ฐ๐—ธ๐—ผ๐˜‚๐˜ ๐—ก๐—ผ๐˜„: https://www.imarcgroup.com/checkout?id=567&method=1

๐—จ๐—ฆ ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ถ๐—ฐ ๐——๐—ฟ๐˜‚๐—ด ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ-๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿด ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ ๐—ช๐—ถ๐˜๐—ต ๐—ž๐—ฒ๐˜† ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€:

The competitive landscape of the US generic drug market has been studied in the report with the detailed profiles of the key players operating in the market.

๐—ฆ๐—ผ๐—บ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ๐˜€๐—ฒ ๐—ธ๐—ฒ๐˜† ๐—ฝ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ:

โ€ข Teva
โ€ข Mylan
โ€ข Actavis (Teva)
โ€ข Sandoz (Novartis)
โ€ข Sun Pharma
โ€ข Par Pharmaceuticals (Endo Pharmaceuticals)
โ€ข Lupin Pharmaceuticals
โ€ข Dr Reddy's
โ€ข Hospira (Pfizer)

๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ฒ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ช๐—ถ๐˜๐—ต ๐—ง๐—ข๐—– & ๐—Ÿ๐—ถ๐˜€๐˜ ๐—ผ๐—ณ ๐—™๐—ถ๐—ด๐˜‚๐—ฟ๐—ฒ๐˜€: https://www.imarcgroup.com/us-generics-market/toc

๐—ž๐—ฒ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

The report has segmented the US generic drug market on the basis of segment, therapy area, drug delivery and distribution channel.

๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜‚๐—ฝ ๐—ฏ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜:
โ€ข Unbranded
โ€ข Branded

๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜‚๐—ฝ ๐—ฏ๐˜† ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—”๐—ฟ๐—ฒ๐—ฎ:
โ€ข CNS
โ€ข Cardiovascular
โ€ข Dermatology
โ€ข Genitourinary/Hormonal
โ€ข Respiratory
โ€ข Rheumatology
โ€ข Diabetes
โ€ข Oncology
โ€ข Others

๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜‚๐—ฝ ๐—ฏ๐˜† ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜†:
โ€ข Oral
โ€ข Injectables
โ€ข Dermal/Topical
โ€ข Inhalers

๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜‚๐—ฝ ๐—ฏ๐˜† ๐——๐—ถ๐˜€๐˜๐—ฟ๐—ถ๐—ฏ๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐—–๐—ต๐—ฎ๐—ป๐—ป๐—ฒ๐—น:
โ€ข Hospital Pharmacies
โ€ข Retail Pharmacies

๐—”๐˜€๐—ธ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐˜ ๐—ณ๐—ผ๐—ฟ ๐Ÿญ๐Ÿฌ% ๐—ณ๐—ฟ๐—ฒ๐—ฒ ๐—ฐ๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ๐—ฑ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:https://www.imarcgroup.com/request?type=report&id=567&flag=C

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

๐—ž๐—ฒ๐˜† ๐—›๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

โ€ข Market Performance (2017-2022)
โ€ข Market Outlook (2023-2028)
โ€ข Market Trends
โ€ข Market Drivers and Success Factors
โ€ข Impact of COVID-19
โ€ข Value Chain Analysis
โ€ข Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—จ๐˜€:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

๐— ๐—ฒ๐—ฑ๐—ถ๐—ฎ ๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜:

Company Name:ย IMARC Group
Contact Person:ย Elena Anderson
Email:ย sales@imarcgroup.com
Phone:ย +1-631-791-1145
Address:ย 30 N Gould St Ste R
City:ย Sheridan
State:ย WY
Country:ย United States
Website:ย https://www.imarcgroup.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Generic Drug Market Size, Share, Key Players, Regional Analysis and Forecast 2023-2028 here

News-ID: 2894856 • Views: โ€ฆ

More Releases from IMARC Group

IT Outsourcing Market Size, Share, Trends And Growth Report 2025-2033
IT Outsourcing Market Size, Share, Trends And Growth Report 2025-2033
Overview IT Outsourcing Market: The IT Outsourcing Market is rapidly evolving, driven by the need for cost efficiency and access to specialized skills. Companies increasingly outsource IT functions such as application development, infrastructure management, and business process outsourcing to third-party vendors. This trend allows organizations to focus on core competencies while leveraging advanced technologies. Key regions include North America, Europe, and Asia-Pacific, with North America leading due to its robust ITโ€ฆ
Urban EV Shift Drives India Electric Scooter Market to USD 3.0 Billion by 2033, Growing at 9.60% CAGR
Urban EV Shift Drives India Electric Scooter Market to USD 3.0 Billion by 2033, โ€ฆ
India Electric Scooter Market 2025-2033 According to IMARC Group's report titled "India Electric Scooter Market Size, Share, Trends and Forecast by Drive, Battery, Product, Battery Fitting, End Use, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including India electric scooter market growth, share, trends, and regional insights. How Big is the India Electric Scooter Industry? The India electric scooter market size was valued USD 1.3 Billion in 2024. Byโ€ฆ
Rising Cyber Threats Push India Cyber Insurance Market to USD 6,907.8 Million by 2033; Growing at 29.26% CAGR
Rising Cyber Threats Push India Cyber Insurance Market to USD 6,907.8 Million by โ€ฆ
India Cyber Insurance Market 2025-2033 According to IMARC Group's report titled "India Cyber Insurance Market Size, Share, Trends and Forecast by Component, Insurance Type, Organization Size, End Use Industry, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including India cyber insurance market forecast, share, growth and regional insights. Market Size & Future Growth Potential: The cyber insurance market in india was valued USD 582.2 Million in 2024. By 2033,โ€ฆ
Human Resource (HR) Technology Market Size, Share, Trends and Forecast 2025-2033
Human Resource (HR) Technology Market Size, Share, Trends and Forecast 2025-2033
Human Resource Technology Market Overview: The human resource (HR) technology market is witnessing significant growth, driven by increasing digital transformation across organizations and the rising need for automation in workforce management. HR technology solutions, including talent acquisition platforms, payroll systems, performance management software, employee engagement tools, and learning & development platforms, are becoming integral to modern businesses. Cloud adoption, AI-powered analytics, and the shift toward remote and hybrid work models haveโ€ฆ

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ